46.81
-0.385(-0.82%)
Currency In USD
| Previous Close | 47.19 |
| Open | 46.94 |
| Day High | 47.7 |
| Day Low | 46.22 |
| 52-Week High | 54.85 |
| 52-Week Low | 20.85 |
| Volume | 162,769 |
| Average Volume | 627,166 |
| Market Cap | 1.73B |
| PE | -360.04 |
| EPS | -0.13 |
| Moving Average 50 Days | 44 |
| Moving Average 200 Days | 36.09 |
| Change | -0.39 |
If you invested $1000 in Harrow Health, Inc. (HROW) 10 years ago, it would be worth $7,933.05 as of January 14, 2026 at a share price of $46.805. Whereas If you bought $1000 worth of Harrow Health, Inc. (HROW) shares 5 years ago, it would be worth $5,532.51 as of January 14, 2026 at a share price of $46.805.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Harrow to Present at Two Investor Conferences in December
GlobeNewswire Inc.
Nov 24, 2025 12:00 PM GMT
NASHVILLE, Tenn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will participate in the following two investor conferences in
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals
GlobeNewswire Inc.
Nov 18, 2025 12:00 PM GMT
NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the acquisition of Melt Pharmaceuticals, Inc. (Melt), a
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025
GlobeNewswire Inc.
Oct 27, 2025 11:00 AM GMT
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on November 11, 2025NASHVILLE, Tenn., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North Ameri